As the smallpox epidemic spreads, Siga Technologies'
Tpoxx oral antiviral smallpox appears to be in high demand
The company said Thursday it secured an estimated $ 13 million
in drug orders, including a $ 11 million
tender from two new countries and a $ 2 million order.
countries in the Asia-Pacific region with a contract for pills.
Phil Gomez, CEO of Siga, said in a statement
of inquiries about access to Tpoxx.